SRX Global Updates Engineered T-Cell Strategy
SRX Global provided an update on its engineered T-cell strategy following a licensing agreement between Pfizer and Starna.
SRX Global provided an update on its engineered T-cell strategy following a licensing agreement between Pfizer and Starna.